Why I'll Never Own Moderna Stock

Thanks to its leading coronavirus vaccine candidate, Moderna (NASDAQ: MRNA) is one of the most-watched stocks of 2020. Its year-to-date growth eclipsed 360% in July -- though it's since pulled back to about 187% -- and the company has also won a total of $2.5 billion in government funding for its vaccine project. Given its present trajectory, why would anyone commit to never owning Moderna's stock?

In my view, there's no single deal-breaking reason to avoid Moderna, but there are quite a few critical issues which in aggregate make the stock too risky for me to own.

Image source: Getty Images.

Continue reading

Source Fool.com